FDA Import Refusal 799-6747046-8/11/2 — NOVARTIS PHARMACEUTICALS N2

NOVARTIS PHARMACEUTICALS N2 — FEI 3014511679

The FDA refused shipment 799-6747046-8/11/2 from NOVARTIS PHARMACEUTICALS N2 (New Zealand) on Feb 9, 2022. The refused product falls under Drugs and Biologics — GLIPIZIDE (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 2 other import refusals on record.

Refusal details

Date
Feb 9, 2022
Country
New Zealand
Product Category
Drugs and Biologics
Product Code
61PDB09 GLIPIZIDE (ANTI-DIABETIC)
Charges
118,3280

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.